The following scientists were selected from a total of 38 applications:
Humanities and cultural studies
Dr. Martin Wallraff (33), University of Bonn, Protestant Theology Department, Church History
The 'chronography' of Sextus Julius Africanus, a Christian author of the early third century, is an important testimony of the beginnings of Christian historical thinking. It is one of the few significant works dating back to pre-Constantinian times, even though only fragments could be preserved. Martin Wallraff intends to prepare a critical edition of this work, including in his study - and thus making accessible - material available in Syrian and Armenian.
Biology and medicine
Dr. Thomas Behr (33), University of Göttingen, Department of Nuclear Medicine
Thomas Behr works in the field of radioimmunotherapy with a view to developing radiopharmaceuticals to treat tumours - such as small cell bronchial carcinoma - for which no effective therapies have existed so far. As tumour cells form different types of receptors, specific peptide-based receptor ligands can be developed to be used for diagnostic and therapeutic purposes.
Dr. Dirk Busch (33), Munich Technical University, Institute for Medical Microbiology, Immunology and Hygiene
Purifying appropriate T cells is a major problem in implementing specific immunotherapies. Dirk Busch will examine T cells, sorted by means of the newly developed MHC tetramer method, for their suitability in specific immunotherapies. Such T cells will first be studied in animal models with a view to using them also in humans, e.g. for viral infections or tumour diseases.
Dr. Dieter Willbold (34), Institute for Molecular Biotechnology, Jena
Dieter Willbold intends to focus on studying tyrosine kinases, i.e. signal transmitting proteins. He aims at determining the three-dimensional structure of certain domains of these proteins and identifying the amino acids involved in their interactio
Contact: DFG press department